NANOG and urinary bladder cancer: Similar phenomenon occurs in bladder cancer, so that curcumin administration (0–50 μM) decreases CD44, CD133, ALDH1, Nanog and Oct4 to impair CSC characteristics in bladder cancer and induce apoptosis and proliferation inhibition.